Characteristics of tau oligomers

Frontiers in Neurology

Volumn 4 JUL, Issue , 2013, Pages

  Ren, Yan ^a   Sahara, Naruhiko ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Antibody; Dimer; Oligomers; Sarkosyl insoluble; Tau

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MONOCLONAL ANTIBODY; OLIGOMER; TAU PROTEIN;

ALZHEIMER DISEASE; ANTIBODY LABELING; CONFORMATIONAL TRANSITION; FRONTOTEMPORAL DEMENTIA; HUMAN; IMMUNOHISTOCHEMISTRY; MICROTUBULE ASSEMBLY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; OLIGOMERIZATION; PARKINSONISM; PATHOPHYSIOLOGY; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; REVIEW; TAUOPATHY;

EID: 84883517948     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00102     Document Type: Review

References (45)

1. Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci (2001) 24:1121-59. doi:10.1146/annurev.neuro.24.1.1121
2. Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol (1997) 41:17-24. doi:10.1002/ana.410410106
3. Denk F, Wade-Martins R. Knock-out and transgenic mouse models of tauopathies. Neurobiol Aging (2009) 30:1-13. doi:10.1016/j.neurobiolaging.2007.05.010
4. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, et al. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science (2001) 293:711-4. doi:10.1126/science.1062382
5. Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science (2005) 309:476-81. doi:10.1126/science.1113694
6. Barghorn S, Mandelkow E. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry (2002) 41:14885-96. doi:10.1021/bi026469j
7. Makrides V, Shen TE, Bhatia R, Smith BL, Thimm J, Lal R, et al. Microtubule-dependent oligomerization of tau. Implications for physiological tau function and tauopathies. J Biol Chem (2003) 278:33298-304. doi:10.1074/jbc.M305207200
8. Chirita CN, Kuret J. Evidence for an intermediate in tau filament formation. Biochemistry (2004) 43:1704-14. doi:10.1021/bi036034b
9. Kuret J, Chirita CN, Congdon EE, Kannanayakal T, Li G, Necula M, et al. Pathways of tau fibrillization. Biochim Biophys Acta (2005) 1739:167-78. doi:10.1016/j.bbadis.2004.06.016
10. Maeda S, Sahara N, Saito Y, Murayama M, Yoshiike Y, Kim H, et al. Granular tau oligomers as intermediates of tau filaments. Biochemistry (2007) 46:3856-61. doi:10.1021/bi061359o
11. Sahara N, Maeda S, Murayama M, Suzuki T, Dohmae N, Yen S-H, et al. Assembly of two distinct dimers and higher-order oligomers from full-length tau. Eur J Neurosci (2007) 25:3020-9. doi:10.1111/j.1460-9568.2007.05555.x
12. Kopke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-Iqbal I. Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem (1993) 268:24374-84.
13. Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, Kayed R. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol Neurodegener (2011) 6:39. doi:10.1186/1750-1326-6-39
14. Berger Z, Roder H, Hanna A, Carlson A, Rangachari V, Yue M, et al. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J Neurosci (2007) 27:3650-62. doi:10.1523/JNEUROSCI.0587-07.2007
15. Greenberg SG, Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci U S A (1990) 87:5827-31. doi:10.1073/pnas.87.15.5827
16. Selkoe DJ. Altered structural proteins in plaques and tangles: what do they tell us about the biology of Alzheimer's disease? Neurobiol Aging (1986) 7:425-32. doi:10.1016/0197-4580(86)90055-2
17. Wisniewski HM, Iqbal K, Grundke-Iqbal I, Rubenstein R. The solubility controversy of paired helical filaments: a commentary. Neurochem Res (1987) 12:93-5. doi:10.1007/BF00971370
18. Ksiezak-Reding H, Binder LI, Yen SH. Alzheimer disease proteins (A68) share epitopes with tau but show distinct biochemical properties. J Neurosci Res (1990) 25:420-30. doi:10.1002/jnr.490250320
19. Alonso AC, Zaidi T, Grundke-Iqbal I, Iqbal K. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci U S A (1994) 91:5562-6. doi:10.1073/pnas.91.12.5562
20. Alonso AC, Grundke-Iqbal I, Iqbal K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med (1996) 2:783-7. doi:10.1038/nm0796-783
21. Lewis J, Mcgowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet (2000) 25:402-5. doi:10.1038/78078
22. Sahara N, Lewis J, Deture M, Mcgowan E, Dickson DW, Hutton M, et al. Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility. J Neurochem (2002) 83:1498-508. doi:10.1046/j.1471-4159.2002.01241.x
23. Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci U S A (2005) 102:6990-5. doi:10.1073/pnas.0500466102
24. Julien C, Bretteville A, Planel E. Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies. Methods Mol Biol (2012) 849:473-91. doi:10.1007/978-1-61779-551-0_32
25. Sahara N, Deture M, Ren Y, Ebrahim A-S, Kang D, Knight J, et al. Characteristics of TBS-extractable hyperphosphorylated Tau species: aggregation intermediates in rTg4510 mouse brain. J Alzheimers Dis (2013) 33:249-63. doi:10.3233/JAD-2012-121093
26. Patterson KR, Remmers C, Fu Y, Brooker S, Kanaan NM, Vana L, et al. Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease. J Biol Chem (2011) 286:23063-76. doi:10.1074/jbc.M111.237974
27. Jicha GA, Bowser R, Kazam IG, Davies P. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res (1997) 48:128-32. doi:10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E
28. Yen SH, Dickson DW, Crowe A, Butler M, Shelanski ML. Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule associated proteins tau and MAP2. Am J Pathol (1987) 126:81-91.
29. Dickson DW, Ksiezak-Reding H, Liu WK, Davies P, Crowe A, Yen SH. Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site. Acta Neuropathol (1992) 84:596-605. doi:10.1007/BF00227736
30. Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature (1996) 383:550-3. doi:10.1038/383550a0
31. Kampers T, Friedhoff P, Biernat J, Mandelkow EM, Mandelkow E. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett (1996) 399:344-9. doi:10.1016/S0014-5793(96)01386-5
32. Perez M, Valpuesta JM, Medina M, Montejo De Garcini E, Avila J. Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. J Neurochem (1996) 67:1183-90. doi:10.1046/j.1471-4159.1996.67031183.x
33. Wilson DM, Binder LI. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am J Pathol (1997) 150:2181-95.
34. Santa-Maria I, Hernandez F, Martin CP, Avila J, Moreno FJ. Quinones facilitate the self-assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers. Biochemistry (2004) 43:2888-97. doi:10.1021/bi035345j
35. Lasagna-Reeves CA, Castillo-Carranza DL, Guerrero-Muoz MJ, Jackson GR, Kayed R. Preparation and characterization of neurotoxic tau oligomers. Biochemistry (2010) 49:10039-41. doi:10.1021/bi1016233
36. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron (1991) 6:487-98. doi:10.1016/0896-6273(91)90052-2
37. Selkoe DJ. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res (2008) 192:106-13. doi:10.1016/j.bbr.2008.02.016
38. Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Guerrero-Munoz MJ, Kiritoshi T, Neugebauer V, et al. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Sci Rep (2012) 2:700. doi:10.1038/srep00700
39. Friedhoff P, Schneider A, Mandelkow EM, Mandelkow E. Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry (1998) 37:10223-30. doi:10.1021/bi980537d
40. Zhang YJ, Xu YF, Chen XQ, Wang XC, Wang JZ. Nitration and oligomerization of tau induced by peroxynitrite inhibit its microtubule-binding activity. FEBS Lett (2005) 579:2421-7. doi:10.1016/j.febslet.2005.03.041
41. Lee HG, Perry G, Moreira PI, Garrett MR, Liu Q, Zhu X, et al. Tau phosphorylation in Alzheimer's disease: pathogen or protector? Trends Mol Med (2005) 11:164-9. doi:10.1016/j.molmed.2005.02.008
42. Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Sarmiento J, Troncoso J, Jackson GR, et al. Identification of oligomers at early stages of tau aggregation in Alzheimer's disease. FASEB J (2012) 6:1946-59.doi:10.1096/fj.11-199851
43. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol (2002) 103:26-35. doi:10.1007/s004010100423
44. Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci U S A (2001) 98:6923-8. doi:10.1073/pnas.121119298
45. Khlistunova I, Biernat J, Wang Y, Pickhardt M, Von Bergen M, Gazova Z, et al. Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs. J Biol Chem (2006) 281:1205-14. doi:10.1074/jbc.M507753200